Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Sun Hoe Lee
Introduction
Sun Hoe Lee is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at combating cancer. His work is characterized by a focus on innovative solutions that address critical health challenges.
Latest Patents
One of Sun Hoe Lee's notable patents is a sulfonamide derivative with a fused pyrimidine skeleton, which has demonstrated an inhibitory effect on epidermal growth factor receptor mutations. This novel compound, represented by Formula I, includes a solvate or a pharmaceutically acceptable salt. The pharmaceutical composition containing this active ingredient has shown effectiveness in suppressing the growth of cancer cells and overcoming drug resistance induced by mutations in the tyrosine kinase domain of epidermal growth factor receptors.
Career Highlights
Sun Hoe Lee is associated with Hanmi Pharm. Co., Ltd., where he continues to contribute to groundbreaking research and development in the pharmaceutical industry. His work has been instrumental in advancing therapeutic options for patients facing challenging health conditions.
Collaborations
Sun Hoe Lee has collaborated with talented coworkers, including Sun Young Jang and Mi Ra Kim. These partnerships have fostered a collaborative environment that enhances innovation and drives the development of effective pharmaceutical solutions.
Conclusion
Sun Hoe Lee's innovative work in the field of pharmaceuticals exemplifies the impact of dedicated inventors on healthcare advancements. His contributions, particularly in cancer treatment, highlight the importance of research and collaboration in developing effective therapies.